|
|
Science Sparks @ ACTREC
|
06th May 2024 |
Vol. No. 13 ; Issue No.629 |
|
Publications
|
1. Jain Y, Agrawal A, Joshi A, Menon S, Gagan P, Murthy V, Purandare N, Shah S, Puranik A, Choudhury S, Shukla V, Dev I, Kumar P, Noronha V, Rangarajan V (2024). Can 18F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer? Nuclear Medicine Communications.
2. Polusany K, Karun H, Rane S, Thiagarajan S (2024). Does the use of intraoperative frozen section of bone marrow from the cut end of the mandible help assess the adequacy of bone margins following mandibulectomy for oral cancer? Journal of Surgical Oncology. .
3. Eekers D, Zegers C, Ahmed K, Amelio D, Gupta T, Harrabi S, Kazda T, Scartoni D, Seidel C, Shih H, Minniti G (2024). Controversies in neuro-oncology: focal proton versus photon radiation therapy for adult brain tumors. Neuro-Oncology Practice..
4. Puranik AD, Dev ID, Rangarajan V, Kulkarni S, Shetty N, Gala K, Sahu A, Bhattacharya K, Dasgupta A, Chatterjee A, Gupta T, Sridhar E, Sahay A, Shetty P, Singh V, Moiyadi A, Menon N, Purandare NC, Agrawal A, Shah S, Choudhury S, Ghosh S, Jha AK. PRRT with Lu-177 DOTATATE in treatment-refractory progressive meningioma: Initial experience from a tertiary-care Neuro-Oncology Center. Neurology India. 72(2):278-284.
5. Bhardwaj P, Arora B, Saxena S, Singh S, Palkar P, Goda J, Banerjee R (2024). Paper-based point of care diagnostics for cancer biomarkers. Sensors and Diagnostics. 3: 504-535.
|
|
|
Interesting Reads
|
Giampazolias E, Pereira da Costa M, Lam KC, Lim KHJ, Cardoso A, Piot C, Chakravarty P, Blasche S, Patel S, Biram A, Castro-Dopico T, Buck MD, Rodrigues RR, Poulsen GJ, Palma-Duran SA, Rogers NC, Koufaki MA, Minutti CM, Wang P, Vdovin A, Frederico B, Childs E, Lee S, Simpson B, Iseppon A, Omenetti S, Kelly G, Goldstone R, Nye E, Suárez-Bonnet A, Priestnall SL, MacRae JI, Zelenay S, Patil KR, Litchfield K, Lee JC, Jess T, Goldszmid RS, Reis E Sousa C (2024). Vitamin D regulates microbiome-dependent cancer immunity. Science. 384(6694): 428-437.
|
|
Video of the Week
|
|
Taking Steps Towards Progress in Peripheral T-Cell Lymphoma. |
|
|
|
|
|
|
Do You Know?
In 1975, Methods were developed to sequence DNA. This technology made it possible to identify and target mutated genes and DNA abnormalities that cause cancer.
|
|
|
Cancer News
|
|
|
|
|
mRNA cancer vaccine reprograms immune system to tackle glioblastoma.
|
Inside Precision Medicine, 01/05/2024
|
The new strategy uses the patient’s own tumor cells to create a personalized vaccine, and also harnesses an engineered complex lipid particle (LP) delivery mechanism, generating multi-lamellar LP aggregates (LPA) that can simultaneously function as vaccines and as immunomodulating agents...
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|